超基因医药 RARE
$15.43 −$0.14 (-0.90%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.43 0.00%
开盘$15.68
昨收$15.57
当日区间$15.12 – $15.97
成交量4.05M
市值$1.57B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$214.00M+28.1% YoY
营业利润-$75.00M+30.6% YoY
净利润-$92.00M+20.0% YoY
摊薄每股收益-$0.90+23.1% YoY
自由现金流-$98.00M+12.5% YoY
经营现金流-$97.00M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率83.1%
营业利润率-73.6%
净利率-81.7%
资产收益率-45.6%
流动比率1.73
负债/资产比率122.5%
现金及投资$292.00M
净现金（净负债）$292.00M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $214.00M | $136.00M | $673.00M | $207.28M | $159.93M |
| 营业总收入 | $214.00M | $136.00M | $673.00M | $207.28M | $159.93M |
| 营业成本 | $34.00M | $30.00M | $109.00M | $29.35M | $27.99M |
| 毛利润 | $180.00M | $106.00M | $564.00M | $177.93M | $131.94M |
| 营业费用 | $255.00M | $275.00M | $1.10B | $291.22M | $302.83M |
| 销售及管理费用 | $88.00M | $88.00M | $349.00M | $87.94M | $86.62M |
| 研发费用 | $167.00M | $187.00M | $750.00M | $203.28M | $216.21M |
| 营业利润 | -$75.00M | -$169.00M | -$535.00M | -$113.28M | -$170.89M |
| 非经营性利息净收入（支出） | -$17.00M | -$15.00M | -$37.00M | -$12.96M | -$8.29M |
| 非经营性利息收入 | $5.00M | $6.00M | $25.00M | $6.51M | $5.86M |
| 非经营性利息支出 | $22.00M | $21.00M | $62.00M | $19.47M | $14.15M |
| 其他收入（支出） | $1.00M | – | $1.00M | -$1.45M | -$365,000.00 |
| 其他非经营性收入（支出） | $1.00M | – | $1.00M | -$934,000.00 | -$1.04M |
| 税前利润 | -$91.00M | -$184.00M | -$571.00M | -$127.69M | -$179.54M |
| 税费 | $1.00M | $1.00M | $4.00M | $870,000.00 | $873,000.00 |
| 净利润 | -$92.00M | -$185.00M | -$575.00M | -$128.56M | -$180.41M |
| 持续经营利润 | -$92.00M | -$185.00M | -$575.00M | -$128.56M | -$180.41M |
| 归属母公司净利润 | -$92.00M | -$185.00M | -$575.00M | -$128.56M | -$180.41M |
| 归属普通股股东净利润 | -$92.00M | -$185.00M | -$575.00M | -$128.56M | -$180.41M |
| 基本每股收益 | -$0.90 | -$1.84 | -$5.83 | -$1.29 | -$1.81 |
| 摊薄每股收益 | -$0.90 | -$1.84 | -$5.83 | -$1.29 | -$1.81 |
| 证券出售收益 | – | – | – | – | $678,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.26B | $1.30B | $1.53B | $1.53B | $1.19B |
| 流动资产合计 | $606.00M | $657.00M | $951.00M | $951.00M | $643.21M |
| 现金及现金等价物与短期投资 | $292.00M | $413.00M | $680.00M | $680.00M | $425.25M |
| -现金及现金等价物 | $125.00M | $175.00M | $421.00M | $421.00M | $202.51M |
| -短期投资 | $167.00M | $238.00M | $259.00M | $259.00M | $222.74M |
| 应收款 | $200.00M | $121.00M | $158.00M | $158.00M | $112.54M |
| -应收账款 | $200.00M | $121.00M | $158.00M | $158.00M | $112.54M |
| 存货 | $59.00M | $55.00M | $52.00M | $52.00M | $52.20M |
| 其他流动资产 | $55.00M | $68.00M | $61.00M | $61.00M | $53.22M |
| 非流动资产合计 | $658.00M | $639.00M | $581.00M | $581.00M | $547.24M |
| 固定资产净值 | $235.00M | $239.00M | $244.00M | $244.00M | $249.96M |
| 投资及预付款 | $144.00M | $121.00M | $57.00M | $57.00M | $22.07M |
| -可供出售证券 | $144.00M | $121.00M | $57.00M | $57.00M | $22.07M |
| 商誉及其他无形资产 | $216.00M | $218.00M | $220.00M | $220.00M | $217.35M |
| -商誉 | $44.00M | $44.00M | $44.00M | $44.00M | $44.41M |
| -其他无形资产 | $172.00M | $174.00M | $176.00M | $176.00M | $172.94M |
| 其他非流动资产 | $63.00M | $61.00M | $60.00M | $60.00M | $57.86M |
| 负债合计 | $1.55B | $1.53B | $1.61B | $1.61B | $1.17B |
| 流动负债合计 | $351.00M | $325.00M | $384.00M | $384.00M | $340.02M |
| 应付款 | $39.00M | $42.00M | $31.00M | $31.00M | $40.57M |
| -应付账款 | $39.00M | $42.00M | $31.00M | $31.00M | $40.57M |
| 一年内应计费用 | $149.00M | $133.00M | $208.00M | $208.00M | $165.25M |
| 一年内预提费用 | $72.00M | $61.00M | $57.00M | $57.00M | $55.28M |
| 其他流动负债 | $91.00M | $89.00M | $76.00M | $76.00M | $66.78M |
| 非流动负债合计 | $1.20B | $1.20B | $1.22B | $1.22B | $834.26M |
| 一年以上递延负债 | $30.00M | $30.00M | $30.00M | $30.00M | $30.06M |
| 其他非流动负债 | $41.00M | $42.00M | $20.00M | $20.00M | $18.78M |
| 股东权益合计 | -$284.00M | -$229.00M | -$73.00M | -$73.00M | $16.16M |
| 股东权益 | -$291.00M | -$236.00M | -$80.00M | -$80.00M | $9.16M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $96,000.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $96,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $4.52B | $4.48B | $4.45B | $4.45B | $4.41B |
| 留存收益 | -$4.81B | -$4.72B | -$4.53B | -$4.53B | -$4.40B |
| 减：库存股 | $10.00M | $10.00M | $8.00M | $8.00M | $7.99M |
| 不影响留存收益的损益 | $0.00 | $0.00 | $1.00M | $1.00M | $820,000.00 |
| 其他权益权益 | $10.00M | $10.00M | $8.00M | $8.00M | $7.99M |
| 少数股东权益 | $7.00M | $7.00M | $7.00M | $7.00M | $7.00M |
| -固定资产原值 | – | – | $380.00M | $380.00M | – |
| -累计折旧 | – | – | -$136.00M | -$136.00M | – |
| 短期债务及融资租赁负债 | – | – | $12.00M | $12.00M | $12.14M |
| -一年内到期融资租赁负债 | – | – | $12.00M | $12.00M | $12.14M |
| 长期债务及融资租赁负债 | – | – | $24.00M | $24.00M | $21.69M |
| -长期融资租赁负债 | – | – | $24.00M | $24.00M | $21.69M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$97.00M | -$197.00M | -$466.00M | -$99.83M | -$91.17M |
| 持续经营经营活动现金流净额 | -$97.00M | -$197.00M | -$466.00M | -$99.83M | -$91.17M |
| 持续经营净利润 | -$92.00M | -$185.00M | -$575.00M | -$128.56M | -$180.44M |
| 折旧、折耗与摊销 | $8.00M | $8.00M | $35.00M | $8.79M | $8.22M |
| 其他非现金项目 | -$18.00M | $2.00M | -$52.00M | -$17.42M | -$11.58M |
| 营运资金变动 | -$29.00M | -$51.00M | -$23.00M | $588,000.00 | $55.41M |
| -应收款变动 | -$62.00M | $19.00M | -$31.00M | -$33.83M | $5.83M |
| -存货变动 | -$3.00M | -$4.00M | -$6.00M | $150,000.00 | -$5.15M |
| -预付资产变动 | $12.00M | -$9.00M | -$10.00M | -$2.74M | $9.74M |
| -应付账款及应计费用变动 | $24.00M | -$57.00M | $24.00M | $37.01M | $44.99M |
| 投资活动现金流净额 | $44.00M | -$49.00M | $236.00M | -$72.25M | $117.25M |
| 持续经营投资活动现金流净额 | $44.00M | -$49.00M | $236.00M | -$72.25M | $117.25M |
| 固定资产购置及出售净额 | -$1.00M | -$1.00M | -$6.00M | -$938,000.00 | -$1.06M |
| 无形资产购置及出售净额 | $0.00 | -$5.00M | -$15.00M | $0.00 | $0.00 |
| 投资购置及出售净额 | $48.00M | -$43.00M | $258.00M | -$71.58M | $119.58M |
| 期末现金余额 | $140.00M | $189.00M | $436.00M | $436.00M | $214.70M |
| 现金净变动 | -$50.00M | -$246.00M | $248.00M | $222.12M | – |
| 期初现金余额 | $189.00M | $436.00M | $184.00M | $214.70M | $189.00M |
| 汇率变动影响 | $1.00M | -$1.00M | $4.00M | -$656,000.00 | -$344,000.00 |
| 自由现金流 | -$98.00M | -$203.00M | -$487.00M | -$100.77M | -$92.23M |
| 其他投资变动净额 | – | – | -$1.00M | $273,000.00 | – |
| 筹资活动现金流 | – | – | $478.00M | $394.19M | -$192,000.00 |
| 持续经营筹资活动现金流净额 | – | – | $478.00M | $394.19M | -$192,000.00 |
| 普通股发行净额 | – | – | $86.00M | $6.27M | -$4.27M |
| 其他筹资费用净额 | – | – | $392.00M | – | – |
暂无评论——快来第一个聊聊 RARE。
登录后参与讨论。